| Secondary |
| Product Used For Unknown Indication |
71.0% |
| Arthritis |
4.3% |
| Hot Flush |
4.3% |
| Alcoholic Liver Disease |
2.9% |
| Hormone Replacement Therapy |
2.9% |
| Inflammation |
2.9% |
| Spinal Disorder |
2.9% |
| Arthropathy |
1.4% |
| Atrial Fibrillation |
1.4% |
| Ill-defined Disorder |
1.4% |
| Pollakiuria |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Ventricular Extrasystoles |
1.4% |
|
| Vomiting |
27.3% |
| Breast Cancer |
9.1% |
| Completed Suicide |
9.1% |
| Death |
9.1% |
| Impaired Driving Ability |
9.1% |
| International Normalised Ratio Decreased |
9.1% |
| International Normalised Ratio Increased |
9.1% |
| Nausea |
9.1% |
| Rhabdomyolysis |
9.1% |
|
| Concomitant |
| Osteoporosis |
23.5% |
| Multiple Myeloma |
7.8% |
| Type 2 Diabetes Mellitus |
7.8% |
| Non-hodgkin's Lymphoma |
5.7% |
| Osteopenia |
5.7% |
| Arthritis |
4.6% |
| Depression |
4.6% |
| Blood Cholesterol Increased |
3.6% |
| Chronic Myeloid Leukaemia |
3.6% |
| Drug Use For Unknown Indication |
3.6% |
| Hormone Replacement Therapy |
3.6% |
| Ill-defined Disorder |
3.2% |
| Multiple Sclerosis |
3.2% |
| Neuralgia |
3.2% |
| Plasma Cell Myeloma |
3.2% |
| Hyperlipidaemia |
2.8% |
| Non-small Cell Lung Cancer |
2.8% |
| Back Pain |
2.5% |
| Gait Disturbance |
2.5% |
| Immunodeficiency Common Variable |
2.5% |
|
| Weight Decreased |
11.4% |
| Myalgia |
7.3% |
| Pain In Extremity |
6.5% |
| White Blood Cell Count Decreased |
6.5% |
| Atrial Fibrillation |
5.7% |
| Rash |
5.7% |
| Vomiting |
5.7% |
| Nausea |
4.9% |
| Pancreatitis |
4.9% |
| Vision Blurred |
4.9% |
| Weight Increased |
4.9% |
| Oedema Peripheral |
4.1% |
| Tooth Disorder |
4.1% |
| Visual Acuity Reduced |
4.1% |
| Drug Ineffective |
3.3% |
| Headache |
3.3% |
| International Normalised Ratio Increased |
3.3% |
| Myocardial Infarction |
3.3% |
| Palpitations |
3.3% |
| Pyrexia |
3.3% |
|
| Interacting |
|
| Cognitive Disorder |
100.0% |
|
